Review: taking Zofran and Marijuana together


Summary

Drug interactions are reported among people who take Zofran and Marijuana together. This review analyzes the effectiveness and drug interactions between Zofran and Marijuana. It is created by eHealthMe based on reports of 84 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Zofran

Zofran has active ingredients of ondansetron hydrochloride. It is often used in nausea. (latest outcomes from Zofran 36,472 users)

Marijuana

Marijuana has active ingredients of marijuana. It is often used in drug abuse and dependence. (latest outcomes from Marijuana 2,740 users)

On Sep, 16, 2016

84 people who take Zofran, Marijuana are studied.


Number of reports submitted per year:

Zofran and Marijuana drug interactions.

Drug effectiveness over time:

Zofran:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 50.0% - (1 of 2 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Marijuana:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 50.0% - (1 of 2 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Zofran:
  • female: 100.0% - (2 of 2 people)
  • male: 0.0% - (0 of 1 people)
Marijuana:
  • female: 0.0% - (0 of 2 people)
  • male: 100.0% - (1 of 1 people)

Drug effectiveness by age:

Zofran:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 0 people)
Marijuana:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

1 - 6 months:
  • cerebrovascular accident
  • hemiplegia
  • myocardial ischaemia
  • nausea
  • pain
  • speech disorder
  • splenic infarction
6 - 12 months:
  • fatigue
  • abdominal discomfort
  • abdominal pain
  • abnormal behaviour
  • application site burn
  • application site irritation
  • application site pruritus
  • back pain
  • bone pain
  • bronchitis
1 - 2 years:
  • abdominal pain upper
  • cholecystitis chronic
  • gallbladder injury
2 - 5 years:
  • chronic sinusitis
  • cognitive deterioration
  • constipation
  • depression
  • diarrhea
  • dry mouth
  • anxiety, apprehension, feeling uptight, jitters, stress, stress and anxiety, tension
  • burning eyes
  • chronic pain
  • chronic pancreatitis
5 - 10 years:
  • genital haemorrhage
  • injury
  • nausea
  • pain
  • vomiting
  • weight decreased
not specified:
  • nausea
  • depression
  • pain
  • vomiting
  • anxiety
  • pyrexia
  • convulsion
  • drug screen positive
  • headache
  • hallucination

Most common drug interactions by gender *:

female:
  • pain
  • nausea
  • depression
  • insomnia
  • anxiety
  • convulsion
  • headache
  • vomiting
  • drug screen positive
  • abdominal pain
male:
  • vomiting
  • nausea
  • depression
  • fatigue
  • pyrexia
  • blood alkaline phosphatase increased
  • haematocrit decreased
  • haemoglobin decreased
  • diarrhoea
  • headache

Most common drug interactions by age *:

10-19:
  • abdominal pain upper
  • cholecystitis chronic
  • gallbladder injury
  • gastritis
20-29:
  • depression
  • anxiety
  • back pain
  • haemoglobin decreased
  • pyrexia
  • abscess jaw
  • ataxia
  • blood alkaline phosphatase increased
  • blood immunoglobulin g increased
  • bone disorder
30-39:
  • anxiety
  • convulsion
  • depression
  • drug screen positive
  • hallucination
  • pain
  • pyrexia
  • insomnia
  • mental disorder
  • vomiting
40-49:
  • dizziness
  • diarrhoea
  • dyspnoea
  • malaise
  • abdominal discomfort
  • abnormal behaviour
  • application site burn
  • application site irritation
  • application site pruritus
  • back pain
50-59:
  • nausea
  • constipation
  • depression
  • lethargy
  • pain
  • vomiting
  • headache
  • anxiety, apprehension, feeling uptight, jitters, stress, stress and anxiety, tension
  • burning eyes
  • chronic pain
60+:
  • diarrhoea
  • nausea
  • urinary tract infection
  • malaise
  • pain
  • pruritus
  • blood creatinine increased
  • abdominal pain
  • abdominal tenderness
  • anaemia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Zofran and Marijuana?

Can you answer these questions?

More questions for: Zofran, Marijuana

You may be interested in these reviews

More reviews for: Zofran, Marijuana

On eHealthMe, Zofran (ondansetron hydrochloride) is often used to treat nausea. Marijuana (marijuana) is often used to treat drug abuse and dependence. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.